<?xml version="1.0" encoding="UTF-8"?>
<p id="par0065">Clinical picture of CRS or cytokine storm strikes suddenly and the main goal, after starting intensive care treatment and targeting the elimination environmental trigger (if possible), is to administer potential drugs capable of controlling cytokine production and its harmful effect. Excessive cytokine production by immunomodulatory drugs has its place on top of contemporary research. From web portal “ClinicalTrials.gov” 27 studies under key words cytokine release syndrome and 32 studies under cytokine storm were analyzed (last accessed 26 August 2020). Out of those trials, not all deal with immunomodulators. Studies involved in the text are summarized in 
 <xref rid="tbl0005" ref-type="table">Table 1</xref> . Three studies are completed, two of them have already been published [
 <xref rid="bib0125" ref-type="bibr">25</xref>,
 <xref rid="bib0130" ref-type="bibr">26</xref>].
</p>
